Epigenetics Podcast #183 - The Epigenetics of the Cannabinoid System with Onder Albayram

Epigenetics Podcast #183 - The Epigenetics of the Cannabinoid System with Onder Albayram

🎙 Onder Albayram 👥 2K 📅 October 9, 2026 ⏱ 46 min 👁 55 📄 expert opinion 🧭 2026-10-15
Available in: English (current) Français

Keywords

CB1 receptoranandamide2-AGhippocampushistone acetylation

Summary

In this episode, host Stefan Dillinger interviews Dr. Onder Albayram from the Medical University of South Carolina about the endocannabinoid system’s role in brain aging and neuroprotection. Albayram recounts his academic journey, starting as an undergraduate at the MRC Laboratory of Molecular Biology in Cambridge, then moving to USC for neuropharmacology and a PhD at the University of Bonn. He explains the endocannabinoid system, including CB1 receptors, endogenous ligands anandamide and 2-AG, and their synthesis/degradation enzymes. His research shows that endocannabinoid tone declines with age in the hippocampus, particularly 2-AG and its biosynthetic enzyme DAGLα, without compensatory receptor upregulation. Genetically deleting CB1 receptors improves learning in young mice but impairs it in old animals. Chronic low-dose THC treatment in old mice rescued cognitive performance and shifted hippocampal gene expression toward a youthful profile after a washout period, involving anti-aging genes like BDNF and Klotho and downregulation of pro-aging genes. These lasting changes suggest epigenetic regulation, possibly via histone acetylation at gene promoters. Albayram discusses current work focusing on GABAergic neurons and the translational potential for human elderly, referencing a Johns Hopkins study on low-dose THC. The conversation highlights the complexity of dosing and the need to understand the system’s homeostatic role.

201 words

Critical Evaluation

Value of the Information & Strength of the Argument

The episode provides substantial value by presenting original research findings from peer-reviewed studies, including behavioral experiments, gene expression analyses, and epigenetic observations. The argumentation is logical and grounded in experimental data, with clear distinctions between established results and speculative interpretations. Albayram carefully explains the evidence for each conclusion, such as the paradoxical effects of CB1 deletion depending on age, and the long-lasting transcriptional changes after THC washout. He also addresses potential limitations, such as the difficulty of translating doses from mice to humans, and acknowledges the stigma surrounding cannabinoid research. The reasoning is coherent and supported by concrete examples, making the information credible and useful for researchers and informed laypersons.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high: Albayram directly references his published studies and mentions a PNAS paper that motivated his work, as well as a later human study from Johns Hopkins. He does not overstate conclusions, often noting when mechanisms remain unclear. The title accurately describes the episode’s focus on the epigenetics of the cannabinoid system, though the content is broader, covering neurobiology and aging. No commercial advertising or sponsored segments appear in the transcript. The source quality is strong, relying on primary research and the speaker’s expertise as a principal investigator. The discussion is well-structured, with clear explanations of concepts and experimental designs.

228 words

Title / Content Match

The title accurately reflects the content: the episode focuses on the endocannabinoid system's role in brain aging and neuroprotection, with a significant emphasis on epigenetic mechanisms.

Quality & Reliability

9/10

The episode features a leading researcher discussing published, peer-reviewed findings and ongoing work, with concrete experimental details and references to prior studies. The speaker maintains a cautious tone, distinguishing between established data and hypotheses.

Key Moments

Contribution & Novelties

This episode provides a unique overview of how endocannabinoid signaling declines with age and how low-dose THC can re-establish a youthful transcriptomic and behavioral state via epigenetic mechanisms. The speaker’s own research links CB1 receptor function, synaptic plasticity, and histone acetylation at promoters of longevity genes, offering a novel perspective on age-related cognitive decline and potential therapeutic interventions.

Pour aller plus loin :

121 words

Radar Profile

The profile shows high scores across quality, reliability, and technical level, with slightly lower but still strong scores for quantity of information, reflecting the focused but detailed nature of a podcast episode. The expert-led discussion provides a balanced and credible scientific account.

Reliability 9/10